Catalyst Wire Dossier Catalyst Wire Dossier

Medroxyprogesterone 1% topical

medroxyprogesterone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Medroxyprogesterone 1% topical, covering 2023-08-02 to 2023-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK [Phase 2, Phase 3]

See pricing